JP2015101541A5 - - Google Patents

Download PDF

Info

Publication number
JP2015101541A5
JP2015101541A5 JP2013240554A JP2013240554A JP2015101541A5 JP 2015101541 A5 JP2015101541 A5 JP 2015101541A5 JP 2013240554 A JP2013240554 A JP 2013240554A JP 2013240554 A JP2013240554 A JP 2013240554A JP 2015101541 A5 JP2015101541 A5 JP 2015101541A5
Authority
JP
Japan
Prior art keywords
enzyme
skin
measured
wrinkles
enzyme activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013240554A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015101541A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013240554A priority Critical patent/JP2015101541A/ja
Priority claimed from JP2013240554A external-priority patent/JP2015101541A/ja
Publication of JP2015101541A publication Critical patent/JP2015101541A/ja
Publication of JP2015101541A5 publication Critical patent/JP2015101541A5/ja
Pending legal-status Critical Current

Links

JP2013240554A 2013-11-21 2013-11-21 皮膚関連酵素活性化剤 Pending JP2015101541A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013240554A JP2015101541A (ja) 2013-11-21 2013-11-21 皮膚関連酵素活性化剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013240554A JP2015101541A (ja) 2013-11-21 2013-11-21 皮膚関連酵素活性化剤

Publications (2)

Publication Number Publication Date
JP2015101541A JP2015101541A (ja) 2015-06-04
JP2015101541A5 true JP2015101541A5 (https=) 2016-10-13

Family

ID=53377549

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013240554A Pending JP2015101541A (ja) 2013-11-21 2013-11-21 皮膚関連酵素活性化剤

Country Status (1)

Country Link
JP (1) JP2015101541A (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6630066B2 (ja) * 2015-06-10 2020-01-15 ポーラ化成工業株式会社 酵素活性化剤
WO2017023690A1 (en) * 2015-07-31 2017-02-09 Exoceuticals, Inc. Exosome compositions and methods for preparation and use thereof for regulating and conditioning skin and hair
JP2022144014A (ja) * 2021-03-18 2022-10-03 丸善製薬株式会社 カスパーゼ-14発現促進剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4562536B2 (ja) * 2005-01-27 2010-10-13 株式会社ノエビア 皮膚外用剤
MX2012001374A (es) * 2009-08-31 2012-03-06 Avon Prod Inc Usos cosmeticos de extractos de levadura estresada modificados y composiciones relacionadas.

Similar Documents

Publication Publication Date Title
JP2013502212A5 (https=)
CN105962343A (zh) 一种猕猴桃酵素及其制备方法
JP2015101541A5 (https=)
JP2015101539A5 (https=)
JP2015101540A5 (https=)
NZ596325A (en) Biomarker for selecting patients and related methods
WO2013179210A3 (en) Process for the selective reduction of bile acids, their salts or derivatives, in a biphasic system
MX2014005400A (es) Metodos para tratar hiperucemia en pacientes con gota utilizando halofenato o acido halofenico y un segundo agente de reduccion de urato.
Garcia-Fraile et al. Plums (Prunus domestica L.) are a good source of yeasts producing organic acids of industrial interest from glycerol
CN102985093A (zh) 用于遏制光暴露导致的异常皮肤细胞的形成的试剂
JP2021118753A (ja) エンドトキシン低減サーモリシン
Cao Association between total antioxidant status and atherosclerosis in elderly patients with essential hypertension
JP2011107124A (ja) 生体情報取得方法
WO2008011134A3 (en) Use of late passage mesenchymal stem cells (mscs) for treatment of cardiac rhythm disorders
WO2007041268A3 (en) Transporter-targeted methods of diagnosis and treatment
JP2017527580A (ja) 老化防止スキンケア組成物及びレジメン
JP2015101541A (ja) 皮膚関連酵素活性化剤
JP6282243B2 (ja) 発酵熟成プラセンタ溶液の製造方法
WO2011129607A3 (en) Method for increasing stem cell activity and stem cells produced thereby
CN108888573B (zh) 舒敏保湿滋润霜及其制备方法
CN118806627B (zh) 一种表皮修护组合物及其制备方法
CN117257696B (zh) 米发酵液冻干粉在制备修复皮肤损伤的产品中的应用
Adjemian et al. Epidemiology Of Pulmonary Nontuberculous Mycobacterial Disease In Patients With Cystic Fibrosis In The United States, 2010-2014
Emani How to manage the pulmonary valve during repair of Tetralogy of Fallot
Aboudara et al. Change in exercise capacity after speech therapy in patients with vocal cord dysfunction